Parexel, a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the launch of the Parexel ...

Good afternoon, and thank you for joining us today for BioAge Labs R&D Day. I'm Chris Patil, VP of Media at BioAge. Before we begin, I would like to remind everyone that during this call, we will be ...

Novo Nordisk’s Ibrahim Kamstrup-Akkaoui outlines how the Danish GLP-1 giant is embedding AI into its clinical foundation.

From original GLP-1 science to international clinical development, Innogen shares its from 0 to 1 innovation journey in ...

Company’s presentation will provide updates on SkinJect® Phase 2b Pivotal Study in patients with Gorlin Syndrome and ...

AMPLIFY-7P did not meet the pre-specified primary endpoint of disease-free survival (“DFS”) in the intent-to-treat population.Randomization ...

NeuroOne Medical Technologies Corporation has appointed Dr. Parag G. Patil as Chief Medical Advisor, leveraging his extensive experience in neurosurgery and medical innovation to drive the company's ...

Great. Good morning, global investors. Thank you for joining CStone Pharmaceuticals' ESMO Data Review Conference Call. The call is going to be mainly focused on the CF2009 data readouts at the recent ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) ...

New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated ...

QuantHealth, the leader in AI-powered clinical trial simulation, today announced the appointment of four executives from the world’s top pharmaceutical and AI organizations to its executive team. The ...

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted ...